When was Archean Sciences founded?

Archean Sciences was founded in 2026 and raised its 1st funding round within a year of its incorporation.

Where is Archean Sciences located?

Archean Sciences is headquartered in Champaign, United States.

How many employees does Archean Sciences have?

As of Aug 31, 2026, the latest employee count at Archean Sciences is 3.

Is Archean Sciences a funded company?

Archean Sciences is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on May 27, 2026.

When was the latest funding round of Archean Sciences?

Archean Sciences' latest funding was a $***** Seed round on May 27, 2026, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.64B in funding in 2026 to date.

Where does Archean Sciences rank among its competitors?

Archean Sciences ranks 39th amongst 57 active competitors, of which 22 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Archean Sciences, which secured $385K in May, 2026.

Who are the top competitors of Archean Sciences?

Archean Sciences' top competitors include CN Bio, Mimetas and Emulate. Among them, Archean Sciences secured the most recent funding round in May, 2026.

Archean Sciences - 2026 Company Profile, Funding & Competitors

Archean Sciences is a seed company based in Champaign (United States), founded in 2026. It operates as a Developer of autonomous brain on a chip systems for research. Archean Sciences has raised $385K in funding. The company has 57 active competitors, including 22 funded and 2 that have exited. Its top competitors include companies like CN Bio, Mimetas and Emulate.

Company Details

Developer of autonomous brain on a chip systems for research. This technology utilizes human neurons in vitro to facilitate closed-loop drug candidate testing. These systems serve as an organic substrate for computation, providing energy-efficient alternatives to traditional silicon-based hardware. This approach aims to address challenges in drug development and neural data processing.

Key Metrics

Founded Year

2026

Location

Champaign, United States

Stage

Seed

Total Funding

$385K in 1 round

Latest Funding Round

Seed, May 27, 2026, $*****

Ranked

39^th among 57 active competitors

Employee Count

3 as on Aug 31, 2026

Similar Companies

CN Bio & 58 more

View Archean Sciences' full profile

Archean Sciences has raised a total funding of $385K over 1 round.

Here is the list of recent funding rounds of Archean Sciences:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 27, 2026	9528075	Seed	6176766	7493208	8643815	2926375

Access funding benchmarks and valuations. Sign up today!

View details of Archean Sciences's funding rounds and investors

Archean Sciences' employee count trend

Archean Sciences has 3 employees as of Aug 26. Here is Archean Sciences's employee count trend over the years:

Employee count trend for Archean Sciences

Uncover Archean Sciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Archean Sciences include CN Bio, Mimetas and Emulate. Here is the list of Top 10 competitors of Archean Sciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CN Bio 2009, Cambridge (United Kingdom), Series B	Develops organ-on-a-chip platforms for drug discovery	$71.2M	CITIC, Zray Management & 13 others	63/100
2nd	Mimetas 2013, Leiden (Netherlands), Acquired	Develops microfluidics-based organ-on-a-chip tissue models	$28.9M	Zeeuws Investerings Fonds, Oost NL & 13 others	60/100
3rd	Emulate 2013, Boston (United States), Series E	Developer of in vitro models for drug development	$204M	ND Capital, Cedars Sinai & 25 others	58/100
4th	Vivodyne 2021, Philadelphia (United States), Series A	Developer of AI-based platform for lab-grown human tissues	$80M	Khosla Ventures, MBX Capital & 6 others	55/100
5th	Okomera 2020, Paris (France), Seed	Developer of a device for in vitro cancer testing using a microfluidic chip	$11.2M	Resonance, Polytechnique Ventures & 5 others	44/100
6th	Numa Biosciences 2007, Woodinville (United States), Acquired	Developer of platform for generating small segments of human tissues and organs in microfluidic chips	$10.7M	SeaChange Fund, Vertical Venture Partners ... & 3 others	43/100
7th	Mepsgen 2019, Seoul (South Korea), Series C	Developer of human organ model chips for pharmaceutical development	$29.3M	E&Investment, Korean Development Bank & 6 others	42/100
8th	Obatala Sciences 2017, New Orleans (United States), Series A	Provider of research enabling products and services to research centers	$3.54M	Ochsner, être & 9 others	41/100
9th	Kirkstall 2006, York (United Kingdom), Seed	Developer of an advanced in vitro systems that mimic human physiology for research	$848K	Braveheart Investment Group, South Yorkshire Investment Fund ... & 13 others	41/100
10th	AxoSim 2014, New Orleans (United States), Series A	Engineering human brain and nerve models for neurological insights	$6.78M	Benson Capital Partners, Great Stuff Ventures ... & 9 others	40/100
39th	Archean Sciences 2026, Champaign (United States), Seed	Developer of autonomous brain on a chip systems for research	$385K	-	19/100